Dose daily Reformed GST Framework in Action by CDSCO By: Dose Daily News Bureau Date: October 11, 2025 Share post: FacebookXPinterestWhatsApp TagsCDSCOGSTMedTech Previous articleAcademic Oversight Tightened by UGC: 54 Private Universities Marked as DefaultersNext articleDrug Pricing Reformed with AstraZeneca & U.S. Partnership Dose Daily News Bureauhttps://dosedailynews.com/ LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. I want inI've read and accept the Privacy Policy. Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats Dose Daily News Bureau - June 15, 2026 Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order Breaking News FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes Breaking News The FDA has outlined its updated strategy for generic drug oversight Breaking News Orionis Biosciences Announces $1.44B Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines Breaking News Dr. Sharadwat Mukherjee Takes Charge as West Bengal Health Minister, Sets Vision for Modern, Equitable Healthcare Breaking News Related articles Breaking News Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats Novo Nordisk (Novo Nordisk A/S) the Danish multinational pharmaceutical major, earlier this week announced that the company had identified an IT security incident involving unauthorised access to... Breaking News Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order The Central Drugs Standard Control Organisation (CDSCO), under the Directorate General of Health Services, Government of India, has... Breaking News FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield® (teplizumab-mzwv) for children aged 8 to... Breaking News The FDA has outlined its updated strategy for generic drug oversight The U.S. Food and Drug Administration (FDA) announced its modernized framework for generic drug oversight, highlighting a dual...